What's New for BTK Inhibitors in B-Cell Malignancies? A Winter Hematology Conference Update

Dr Woyach discusses new clinical data with BTK inhibitors in both chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/965742?src=mkm_podcast_addon_965742

Episode metadata supplied by the publisher feed · Published Jan 5, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

What's New for BTK Inhibitors in B-Cell Malignancies? A Winter Hematology Conference Update

0:00 18:20

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Keeping Current CME?

This episode is 18 minutes long.

When was this Keeping Current CME episode published?

This episode was published on January 5, 2022.

Can I download this Keeping Current CME episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!